Neurosurgery Awareness Month 2026: Make Access and Follow-Through Visible

Neurosurgical care tests an organization at its boundaries. A person may begin in primary care, an emergency department, a community hospital, an oncology clinic, a rehabilitation setting, or another health system. Images, examinations, prior records, insurance information, operating capacity, critical-care beds, specialist availability, transportation, caregiver readiness, and follow-up plans can all determine whether the next step happens reliably. Every department can perform its own task and the pathway can still fail if no one owns the connections.

The executive view therefore starts before a procedure is scheduled and continues after discharge. It includes how a referral is received, how urgency is reviewed, whether essential information is available, how declined or deferred cases are tracked, how transfers are coordinated, how diagnostic and operating capacity are balanced, how the perioperative team manages risks, how goals and expectations are documented, and how recovery services reconnect with the clinical team. A reliable pathway is visible at the points where responsibility changes.

Access is more than the number of appointments on a template. It includes geographic reach, referral quality, response time, diagnostic readiness, subspecialty fit, financial and language access, transportation, caregiver support, and the ability to return for surveillance or rehabilitation. A scoping review of 89 global neurotrauma studies described persistent disparities in access, infrastructure, training, research, and data, especially in low- and middle-income settings.⁴ The review organizes a broad literature rather than proving that one intervention will close those gaps. It supports a governance question that applies in many settings: where does the local pathway rely on resources that some people cannot reliably reach?

Waiting lists make that question visible but not simple. An ethical review of neurosurgical waiting lists emphasizes justice, transparency, accountability, prioritization, and stewardship.⁶ Much of the evidence considered by that review comes from outside neurosurgery, so it should not be treated as a clinical prioritization method. Its value for leaders is the insistence that a list is not passive inventory. It is a set of people whose conditions, readiness, contact information, preferences, and risk may change while they wait. A defensible system needs explicit ownership, recurring review, a route for changed circumstances, and clear communication about what the organization can and cannot promise.

Capacity decisions also require honesty about tradeoffs. One high-volume National Health Service center reported that its neurosurgical waiting list grew from 782 in December 2019 to 1,388 in December 2021, then decreased at about 18 cases per month during a later period. The authors modeled faster recovery under extended-service and increased-rate scenarios.¹² Those numbers are historical, local, and modeled. They are not current targets for another institution. They illustrate why boards should ask what additional operating time would require in staffing, beds, diagnostics, recovery capacity, fatigue controls, and opportunity cost before assuming that more sessions alone solve the backlog.

The pathway includes choices that may not involve an operation. Consultation, diagnostic clarification, surveillance, nonsurgical management, supportive care, rehabilitation, and goals-of-care work can be the right next step depending on the person and condition. Governance that values only surgical volume can distort access and underinvest in these essential functions. The operating aim should be appropriate, timely, coordinated care, not simply more procedures.

Leadership begins with a bounded promise. For one defined population or service, the organization will make referral status visible, assign an accountable owner at every handoff, identify capacity constraints, review exceptions, support the workforce, and measure whether the person reaches the next intended step. The promise must be specific enough to test. It might focus on emergency transfers from three referring hospitals, time-sensitive tumor referrals, discharge follow-through after traumatic brain injury, or a waiting-list segment with repeated cancellations. The first improvement cycle should be narrow enough to observe and important enough to matter.

A pathway map should begin with what the person needs to reach next, not with an organizational chart. A referral must become a decision about review and disposition. An accepted transfer must become a coordinated movement with the required information, capacity, and receiving team. A decision to operate must become readiness across diagnostics, consent, equipment, staffing, anesthesia, bed planning, and patient goals. A discharge must become a workable recovery plan with clear contacts and follow-up. Each transition needs an owner, minimum information, an expected next action, and a visible exception route.

The first stage requires a closed-loop intake method. Referrals can arrive by electronic order, telephone, portal, fax, transfer center, emergency consultation, or clinician-to-clinician message. If each channel creates a different queue, leaders may not know how many requests are active or which were abandoned after missing information. The intake design should create one traceable case identity, preserve the original request, record what is missing, assign the task of obtaining it, and show the requesting team what will happen next. Rejection without a documented next step can transfer risk back to the referring site without ensuring continuity.

The second stage is clinical and must remain under qualified authority, but executives still govern its reliability. They can ensure that review expectations are explicit, coverage is known, subspecialty routing is maintained, and dispositions are recorded in a way that downstream teams can act on. A small retrospective study of 29 patients with primary central nervous system lymphoma examined associations among early workflow, corticosteroid exposure before biopsy, MRI-to-biopsy timing, and survival trajectories.⁷ Conventional statistical significance was not reached, and the findings do not establish causality or a universal timing rule. The study supports careful pathway review when diagnostic and treatment steps are interdependent, not a patient-specific recommendation.

The third stage converts a disposition into access. That may require an emergency transfer, an outpatient appointment, further imaging, insurance authorization, transportation, interpreter services, or a planned return after another evaluation. A short informatics report mapped 2,825 neurosurgical transfers and referrals from 2023 through 2025 and made changes in cooperation patterns visible after a leadership transition.⁵ The report does not prove that mapping improved patient outcomes. It shows how referral-flow visualization can reveal relationships and changes that aggregate volume alone may hide.

The fourth stage depends on shared readiness. Surgeons, anesthesiologists, nurses, technologists, diagnostic services, blood bank, equipment teams, sterile processing, pharmacy, critical care, and bed management may all contribute. A scheduled start time does not prove readiness. The team needs a common view of what is complete, what is pending, who owns each exception, and what conditions require a pause. The design should accommodate complexity rather than relying on heroic coordination by one individual.

The fifth and sixth stages prevent the hospital episode from becoming a disconnected endpoint. Recovery includes neurologic status, pain and symptom management, function, communication, swallowing or mobility needs when relevant, caregiver capacity, emotional needs, medication understanding, goals, rehabilitation, equipment, destination, and follow-up. Not every person requires every service. The pathway needs a method to identify needs, assign ownership, and confirm completion. Follow-through is a system result, not a document produced at discharge.

The owner column should be adapted to local structure. Accountability does not mean one person performs every task. It means one role can see whether the stage is complete, convene the necessary contributors, and escalate when the normal route fails. Backup coverage matters. A pathway that functions only when a particular coordinator is present is not reliable.

The handoff evidence should be minimal and usable. Adding fields can make a checklist look complete while increasing delay and workarounds. Teams should identify the small set of information required to act safely, test whether it is available at the decision point, and remove duplicate documentation when possible. The goal is shared situational awareness, not documentation volume.

Exception signals deserve equal status with routine metrics. A missed image, a declined transfer, a repeated cancellation, an unresolved equipment question, an absent caregiver, or an incomplete follow-up can reveal more about the pathway than an average. The organization should distinguish normal variation from conditions that need immediate clinical escalation. Improvement governance cannot define clinical urgency, but it can ensure that authorized clinical routes are reachable and that operational exceptions do not disappear between queues.

Neurosurgical safety depends on technical expertise and on the conditions surrounding that expertise. Long procedures, specialized equipment, imaging, positioning, multiple disciplines, relief coverage, specimen handling, medication, and postoperative destination can create dense coordination demands. The safe response is not a longer generic checklist. It is a reliable set of shared pauses, visible readiness criteria, clear ownership, and an escalation route that the team can use without fear or ambiguity.

The 16-year event-report study provides one lens. Needles, device fragments, cotton material, and device loss all represented substantial shares of the 543 reports.¹ Local teams should compare that descriptive pattern with their own events and near misses. They might review whether counts are standardized across staff changes, how device breakage is recognized, whether supplies are visually distinctive, how unexpected items enter the field, what imaging or other support is available after a discrepancy, and whether documentation supports learning. The study does not identify one control that can be adopted without local evaluation.

Access and capacity failures can enter the operating room as late starts, rushed preparation, deferred cases, unavailable postoperative beds, or staff working beyond planned hours. Information and technology failures can involve images that do not arrive, conflicting patient identifiers, incomplete medication information, or systems that display different versions of the plan. Teamwork and handoff failures can occur at shift change, relief, specimen transfer, count reconciliation, anesthesia transition, ICU handoff, or an urgent change in the procedure. Each branch should be tested through observation and case review rather than assumed from a diagram.

Equipment and environment review should include device condition, availability, compatibility, maintenance, setup, labeling, storage, lighting, noise, traffic, and the physical placement of countable items. Human factors matter because the safest process must work under actual conditions. If a control depends on perfect memory or on one person noticing a subtle discrepancy while managing several competing demands, the design is fragile. Teams can simplify, standardize, make status visible, reduce unnecessary interruptions, and preserve an unambiguous stop-and-reconcile step.

Patient and caregiver needs belong in the perioperative system. Communication preferences, language access, decision support, goals, functional baseline, caregiver availability, and expected recovery can affect preparation and transition. A feasibility randomized trial involving 36 participants compared mixed-reality 3D brain imaging with a standard monitor during neurosurgical consultation. Participants in the mixed-reality group reported higher satisfaction, understanding, and confidence, with no major technology-related or adverse effects reported.¹³ The study was small and designed for feasibility. It does not establish effectiveness or justify a universal technology investment. It supports testing whether communication tools help people understand the plan in a specific setting.

A huddle should resolve decisions, not merely recite them. The team can confirm the intended plan, patient-specific considerations, imaging and equipment readiness, anticipated transitions, critical steps, blood and medication needs, specimen handling, item-accounting expectations, postoperative destination, and the conditions that require a pause. The content should be adapted by qualified teams and should not displace existing regulatory or professional requirements.

Leadership behavior determines whether escalation is real. Staff need to know that a count discrepancy, device concern, missing image, communication problem, or readiness gap can stop progress until the right people review it. Leaders should monitor whether pauses occur, how quickly support arrives, and whether people experience retaliation or dismissal after raising concerns. Psychological safety is not separate from technical safety. It determines whether weak signals enter the learning system soon enough to matter.

Corrective action should be verified in the environment where the work occurs. Training may be appropriate, but it is not a default response to every event. Leaders should ask whether equipment, layout, staffing, scheduling, information flow, authority, or workload contributed. An action is not complete when a policy is approved. It is complete when the intended control is present, usable, understood, and observed in practice, and when new burdens have been checked.

Neurosurgical pathways depend on specialized people whose expertise cannot be added instantly when demand rises. Surgeons, advanced practice clinicians, nurses, anesthesiologists, technologists, therapists, intensivists, coordinators, and support staff work across high-consequence decisions and emotionally difficult outcomes. Capacity planning that treats these roles as interchangeable units can create unsafe schedules, delayed care, turnover, and hidden dependence on individual heroics.

Workforce governance should include coverage, experience mix, supervision, onboarding, relief, fatigue, call burden, cross-training, psychological safety, and access to support after difficult events. The event-report study found associations between reported events and less-experienced surgical or nursing staff as well as procedures lasting six hours or longer.¹ Those findings do not establish individual blame or causality. They support asking whether the system anticipates experience needs, structures supervision, plans transitions, and protects attention during long or complex cases.

Emotional burden is also part of the operating environment. A 2026 cross-sectional survey of 41 professionals at one tertiary children's hospital examined professional grief and moral distress in pediatric neuro-oncological neurosurgery. Most respondents reported recent exposure to advanced or terminal disease. Mean grief and burden scores were high in that local sample, while reported organizational support was lower. Training was associated with lower burden, and exposure correlated with higher scores.² The study is small, single-center, and exploratory. It does not estimate prevalence across the workforce.

The leadership response should not reduce grief and moral distress to personal resilience. Teams need protected debriefing options, access to confidential support, psychologically safe supervision, workload review, ethical consultation when appropriate, and leaders who acknowledge the emotional reality of the work. Training may help people recognize and respond to burden, but training cannot compensate for chronic understaffing, impossible tradeoffs, or a culture that discourages help-seeking.

A narrative report describes a confidential peer-to-peer support model led by senior colleagues in an academic neurosurgery department after adverse outcomes.³ It is a model description rather than an outcomes trial. Organizations considering peer support should define confidentiality, training, boundaries, escalation for urgent needs, access across roles, and protection from performance-management misuse. Utilization and impact should be evaluated without exposing individuals who seek help.

Governance connects workforce support with quality. A recurring adverse event may reveal a technical issue, but it may also reveal staffing transitions, fatigue, supervision gaps, unclear authority, or poor access to equipment. An access delay may look like a scheduling problem while reflecting vacancy, burnout, or an unsustainable call structure. Board-level reporting should include workforce conditions alongside volume and finance so leaders can see when short-term throughput depends on long-term depletion.

Regional and global workforce constraints require partnership. The neurotrauma scoping review describes training, collaboration, infrastructure, technology, and data as connected domains.⁴ Local organizations can participate through shared education, consultation relationships, transfer improvement, data standards, and responsible technology support. Partnerships should be reciprocal and should not extract expertise or data without local benefit, governance, and acknowledgment.

Ethics should be integrated into routine decisions. Waiting lists, transfer acceptance, operating capacity, research participation, technology investment, and end-of-life care all involve competing needs and uncertain evidence. The ethical waiting-list review provides a framework for transparency and accountability, while the palliative-care study highlights how goals and place of care can become visible in the record.^{6, 15} Neither supplies a universal decision rule. Leaders should ensure that qualified clinical and ethics resources are available and that operational pressure does not silently become the prioritization method.

A 90-day cycle is long enough to establish governance, map one pathway, collect a practical baseline, test several low-risk operating changes, and review early performance. It is not long enough to prove long-term clinical outcomes, resolve a regional workforce shortage, or validate a universal model. The aim is to improve the operating conditions leaders can directly influence while protecting clinical authority and evidence boundaries.

During days 1 through 30, leaders should resist the urge to begin with a new dashboard. First define the pathway and the decision the organization wants to improve. A useful scope identifies the population, entry point, end point, exclusions, clinical owner, operational owner, and partners. A transfer pathway might begin when a request is received and end when the person reaches the agreed destination or a documented alternative is communicated. A discharge pathway might begin during inpatient planning and end when follow-up and rehabilitation connections are completed or an exception is assigned.

Mapping should follow real cases. Policies show the intended route, while observation and interviews show how work actually happens. The team should trace several recent journeys, including one that proceeded smoothly, one delayed by missing information, one involving an operational decline or cancellation, and one with a recovery or follow-up exception. Protect privacy, avoid speculative blame, and distinguish clinical decisions from operational defects. The map should identify duplicate queues, manual workarounds, single points of failure, and tasks that depend on personal relationships.

Listening should include people who experience the handoffs. Patients and caregivers can describe unclear communication, travel burden, digital friction, repeated history-taking, or uncertainty after discharge. Referring teams can identify which information is hard to obtain and where responses disappear. Nurses, coordinators, technologists, therapists, and support staff can identify the recovery work that formal process maps overlook. Participation should be accessible and should not ask one person to represent an entire population.

The baseline should be small and credible. Count active requests, identify how many have an owner and next action, decompose a limited set of timing intervals, audit a sample of discharge and follow-up records, review recent safety events or near misses, and collect a short workforce and patient-experience pulse. Correct obvious low-risk gaps, such as an unowned queue or an outdated contact list, without waiting for a perfect dataset. Preserve an annotation of what changed.

During days 31 through 60, test a package that crosses boundaries. For access, create one shared active-case view and an escalation method for silence or missing information. For safety, test a visible readiness or item-accounting control with the relevant perioperative teams. For recovery, test a clear contact route, a closed-loop rehabilitation connection, or an audit-plus-feedback process for discharge communication. The package should include ownership, backup, and measurement, not only a form or education session.

Evidence should shape questions and boundaries. Referral mapping can reveal changes but does not prove outcome benefit.⁵ Waiting-list modeling can expose capacity assumptions but does not set a universal rate.¹² Event-report distributions can focus local review but do not provide comparative incidence.¹ Documentation studies can identify recorded gaps but do not reconstruct every conversation.⁸ Local testing turns these directional insights into an operating design that fits the setting.

The test should include recovery from exceptions. What happens when required imaging is unavailable, a bed changes, transport is delayed, a count does not reconcile, a caregiver cannot participate at the planned time, a rehabilitation service declines, or a follow-up appointment is missed? The team should simulate or observe selected scenarios within authorized safety processes. Reliability is the ability to detect, escalate, and recover, not the absence of all variation.

During days 61 through 90, verify the controls in actual work. Ask whether the active-case view is current, whether backup coverage is real, whether staff can escalate, whether patients know whom to contact, whether referrals close, whether corrective actions persist, and whether the change has shifted burden to another team or population. Compare performance across times, sources, and relevant groups where sample size and privacy allow. A favorable average should not hide a repeating exception.

The governance review should make one of four decisions. Sustain when the design is usable, owned, resourced, and supported by local evidence. Adapt when the purpose is sound but the process remains fragile. Stop when the change adds risk or work without addressing the actual problem. Study further when uncertainty is material and the available data cannot support a responsible decision. These outcomes are all legitimate if the reasoning and evidence are documented.

Spread is a new implementation decision. Another hospital, clinic, subspecialty, or population may have different coverage, technology, transport, language, staffing, capacity, or community resources. The spread package should state the purpose, minimum safety and governance requirements, adaptable elements, measurement definitions, and conditions that require new clinical review. Copying the visible tool without the underlying relationships can reproduce the appearance of reliability without its function.